HomeBUSINESS
BUSINESS

Kyowa Kirin Sets Up New Firm for Nesp Authorized Biosimilar
(Feb.1.2017)

Kyowa Hakko Kirin said on January 31 that it has established a new company, Kyowa Kirin Frontier, which will be working to obtain Japanese regulatory approval for an authorized biosimilar version of its core renal anemia treatment Nesp (darbepoetin alfa) ...
(LOG IN FOR FULL STORY)